Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This former paratrooper with the 82nd Airborne Division shares his experience with hepatitis C at Hep Stories.
Connie Welch’s interview of John M, who was successfully treated and cured from hepatitis C in 2014 with Harvoni.
This Ukrainian woman didn’t let outdated hepatitis C treatment or limited access to them, prevent her from getting necessary medical care.
The two-drug regimen can cure the virus in as little as eight weeks.
The move could help dramatically expand access to affordable hep C treatment around the world.
Maviret and Vosevi were highly effective and well tolerated in clinical trials.
If successful, the attempt could make cheaper generic versions of sofosbuvir (Sovaldi) available across the continent.
Important information If you are Black and your medical provider prescribes 8 weeks of hepatitis C treatment using Harvoni.
Merck has long argued that Gilead infringed on a patent-protected biotech invention as the basis for its next-generation hepatitis C cures.
The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.
German study shows high hepatitis C virus cure rates after eight weeks of Harvoni (ledipasvir/sofosbuvir) treatment.
Gilead has tested the addition of the investigational voxilaprevir to its already approved Epclusa (sofosbuvir/velpatasvir).
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.